Mitral Valve Prolapse (MVP) is a common heart valve condition characterized by the improper closing of the valve between the heart's upper and lower left chambers, the atrium and ventricle. In individuals with MVP, the valve's flaps, known as leaflets, bulge or collapse backward into the atrium, causing a regurgitation of blood. While many people with MVP may not experience symptoms, others may encounter chest pain, palpitations, or fatigue. The exact cause of MVP is often unknown, but it can be associated with connective tissue disorders. Diagnosis typically involves echocardiography, which allows visualization of the valve's structure and function. Treatment is often unnecessary for those without symptoms, but in severe cases, medications or, in rare instances, surgery may be recommended to repair or replace the valve. Regular monitoring and consultation with healthcare professionals are essential for managing Mitral Valve Prolapse effectively.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation